Skip to main content
Top
Published in: Journal of General Internal Medicine 15/2023

12-09-2023 | Chronic Inflammatory Bowel Disease | Clinical Image

Lung Nodules in a 24-Year-Old Male with Crohn’s Disease

Authors: Caleb J. Murphy, MD MBA, Andrew E. Williams, MD, Maylyn S. Martinez, MD MSc

Published in: Journal of General Internal Medicine | Issue 15/2023

Login to get access

Excerpt

A 24-year-old male with Crohn’s disease presented with shortness of breath. Computed tomography imaging of the chest revealed bilateral pulmonary nodules with varying degrees of cavitation (Fig. 1). Nodule pathology showed central abscess and necrosis with surrounding inflammation and fibrosis (Fig. 2). Infectious and rheumatologic workup was negative, including Gram and acid-fast stains of the biopsy specimen. Presentation, imaging, and pathology were felt to be consistent with necrobiotic pulmonary nodules secondary to inflammatory bowel disease (IBD). Initiation of glucocorticoids resulted in rapid improvement, and the patient was discharged with close follow-up.
Literature
Metadata
Title
Lung Nodules in a 24-Year-Old Male with Crohn’s Disease
Authors
Caleb J. Murphy, MD MBA
Andrew E. Williams, MD
Maylyn S. Martinez, MD MSc
Publication date
12-09-2023
Publisher
Springer International Publishing
Published in
Journal of General Internal Medicine / Issue 15/2023
Print ISSN: 0884-8734
Electronic ISSN: 1525-1497
DOI
https://doi.org/10.1007/s11606-023-08398-8

Other articles of this Issue 15/2023

Journal of General Internal Medicine 15/2023 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine